Smart-Money SignalNeutral · 50/100— Insiders are net sellers over 90 days (-$45K, 3 sales vs 1 buy)
Revenue$2.8M
Net Income-$25.0M
EPS$-0.26
Market Cap$319.0M
Price Performance
Historical data including institutional events
Company Profile
J
James Mullen
CEO & Executive Director
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
